High Frequency Episodic Migraine Shift to Low Frequency Episodic Migraine in Patients Treated with Galcanezumab

被引：0
|
作者：
Stauffer, Virginia [1 ]
Jedynak, Jakub [1 ]
Gendolla, Astrid [2 ]
Eross, Eric [3 ]
Jin, Leah [4 ]
机构：
[1] Eli Lilly & Co, Indianapolis, IN 46285 USA
[2] Praxis Gendolla, Essen, Germany
[3] Phoenix Headache Inst, Phoenix, AZ USA
[4] Covance Inc, Princeton, NJ USA
来源：
NEUROLOGY | 2020年 / 94卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
1772
引用
收藏
页数：3
相关论文
共 50 条
  • [41] Phase 3 studies (EVOLVE-1 & EVOLVE-2) of galcanezumab in episodic migraine: subgroup analyses of efficacy by low-versus high-frequency of migraine headaches
    Silberstein, Stephen
    Stauffer, Virginia L.
    Day, Katie
    Zhang, Qi
    Lipsius, Sarah
    Wilson, Maria-Carmen
    JOURNAL OF HEADACHE AND PAIN, 2018, 19
  • [42] Fremanezumab improves quality of life in patients with high- and moderate-frequency episodic migraine
    Ning, Xiaoping
    Campos, Verena Ramirez
    Barash, Steve
    Cohen, Joshua
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2021, 429 : 209 - 210
  • [43] Efficacy of botulinum toxin type A in high frequency episodic migraine: a preliminary study
    Medeiros, B.
    Pinto, M. J.
    Pinto, M.
    Costa, A.
    JOURNAL OF HEADACHE AND PAIN, 2024, 25
  • [44] A clinical comparison demonstrates similarities between chronic and high frequency episodic migraine
    Pozo-Rosich, P.
    Quintana, M.
    Torres, M.
    Fernandez-Morales, J.
    Alvarez-Sabin, J.
    JOURNAL OF HEADACHE AND PAIN, 2014, 15
  • [45] Episodic Migraine
    Wiebrecht, Axel
    DEUTSCHE ZEITSCHRIFT FUR AKUPUNKTUR, 2019, 62 (02): : 143 - 143
  • [46] Sustained Reduction of Migraine Headache Days in Patients with Episodic Migraine During Months 4 to 6 of Treatment with Galcanezumab
    Tepper, Stewart J.
    Ruff, Dustin
    Wietecha, Linda
    NEUROLOGY, 2020, 94 (15)
  • [47] Eptinezumab Reduces the Frequency of Acute Medication Usage in Patients with Episodic or Chronic Migraine
    Tepper, S. J.
    Smith, T.
    Kassel, E.
    Smith, J.
    Snapinn, S.
    Hirman, J.
    Cady, R.
    HEADACHE, 2019, 59 : 162 - 163
  • [48] Effect of Galcanezumab on Severity of Headache and Associated Symptoms of Migraine in Phase 3 Trials in Patients with Episodic or Chronic Migraine
    Day, Kathleen A.
    Ament, Michael
    Stauffer, Virginia L.
    Skljarevski, Vladimir
    Rettiganti, Mallikarjuna
    Pearlman, Eric M.
    Aurora, Sheena K.
    NEUROLOGY, 2019, 92 (15)
  • [49] Sustained Reduction of Migraine Headache Days in Patients With Episodic Migraine During Months 4 to 6 of Treatment With Galcanezumab
    Ferrari, Michel D.
    Tepper, Stewart J.
    Ruff, Dustin
    Wietecha, Linda
    CEPHALALGIA, 2019, 39 : 217 - 217
  • [50] Immunogenicity findings from Phase 3 galcanezumab trials in patients with episodic or chronic migraine
    Martinez, James M.
    Garce, Sandra
    Anglin, Greg
    Hodsdon, Michael
    Kielbasa, William
    Moser, Brian A.
    Pearlman, Eric
    JOURNAL OF HEADACHE AND PAIN, 2018, 19
12345